Reconstitution Solution: How to Reconstitute Drugs

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Reconstitution is the process of turning a dry powder into a liquid medicine by adding a measured volume of diluent. Many veterinary drugs ship as lyophilized (freeze-dried) powder or as a sterile powder in a vial because the dry form lasts far longer on the shelf than a liquid would. The moment you add liquid, a clock starts. The drug begins to degrade, and the rate of that degradation depends on the drug, the diluent you chose, the final concentration, the storage temperature, and how cleanly you handled the vial.

This guide walks through the full method: verifying the label, selecting the correct diluent, swabbing the stopper, injecting with pressure equalization, swirling instead of shaking, calculating the concentration you actually made, and storing the result within its beyond-use window. The hands-on time is typically 2 to 5 minutes per vial. The elapsed time matters much more, because the reconstituted solution may be usable for only a few hours at room temperature or for weeks under refrigeration or freezing depending on the product.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

What Reconstitution Achieves and When It Is Used

A reconstitution solution exists to convert a stable dry powder into an injectable or administrable liquid at a known concentration. The dry powder is manufactured under sterile conditions and sealed in a vial with a rubber stopper and metal crimp. In that state, most drugs resist hydrolysis and oxidation because there is almost no water present to drive those reactions. Water is the enemy of many drug molecules, and removing it is the single most effective way to extend shelf life.

Reconstitution is used in several common clinical situations:

• Lyophilized injectable antibiotics such as cefuroxime, meropenem, cefovecin, vancomycin, and ceftazidime. These are reconstituted with sterile water for injection, 0.9% sodium chloride, or a specific buffer, then often diluted further into an infusion bag [1][2][3].
• Intravitreal preparations for ophthalmic procedures, where a small volume of highly concentrated drug is drawn into a syringe and sometimes frozen for later use [4].
• Intravesical instillations such as mitomycin C for bladder treatment, reconstituted in either saline or water for injection depending on the product [5].
• Oral suspensions for pediatric or small-animal use, where a powder is reconstituted with a specified volume of purified water and then refrigerated [6].
• Desensitization protocols, where a pharmacy prepares a series of dilutions from a reconstituted stock to deliver gradually increasing amounts of an allergen or drug [7].

The method matters because the same powder reconstituted with the wrong diluent can degrade faster, precipitate, or lose potency. Mitomycin C is a clear example. When reconstituted with the prepackaged 0.9% sodium chloride, the solution degraded rapidly and fell below 90% of its labeled concentration within 24 hours at room temperature. When the same drug was reconstituted with water for injection, degradation was slower and concentrations stayed above the limit longer [5]. The diluent is not interchangeable.

Materials and Reagents

Working concentrations vary by product. Cefuroxime sodium has been studied at 1.5 g in 15, 16, or 18 mL of water for injection, giving roughly 100, 94, or 83 mg/mL respectively [1]. Cefuroxime has also been studied at 90 mg/mL in 0.9% saline for continuous infusion [8]. Meropenem has been studied at 10, 20, and 40 mg/mL in 0.9% sodium chloride [3]. Mitomycin C is typically reconstituted to 1 mg/mL [5]. These are study concentrations, not dosing recommendations. Always follow the product label and your formulary for the concentration your patient needs.

Step-by-Step Reconstitution Procedure

Step 1: Verify the Label and Expiration Date

Read the vial label before you open anything. Confirm the drug name, the total mass of powder in the vial, the lot number, and the expiration date. Check that the powder looks as expected. Lyophilized powders are usually a white to off-white cake or plug at the bottom of the vial. Discoloration, clumping, or a melted appearance suggests the product was exposed to heat or moisture and should not be used.

Check the diluent label too. Sterile water for injection, 0.9% sodium chloride, and 5% dextrose are not interchangeable for every drug. Some products specify a particular diluent, and using the wrong one can change pH, osmolarity, or stability. Mitomycin C products, for example, may be supplied with a prepackaged diluent that is either saline or water, and the resulting solution behaves differently [5].

Step 2: Choose the Correct Diluent

The diluent is the liquid you add to the powder. The three most common choices in veterinary practice are:

• Sterile water for injection (WFI): Pure water with no additives. It is hypotonic, meaning it has lower osmolarity than body fluids, so it is usually not given directly into a vein in large volumes. It is often the preferred diluent for the initial reconstitution step because it avoids adding ions that could affect the drug.
• 0.9% sodium chloride (normal saline): Isotonic and compatible with most drugs. It is the default diluent for many injectable antibiotics and for drugs that will be further diluted into infusion fluids [3][9].
• 5% dextrose in water (D5W): Provides glucose as well as water. Some drugs are more stable in dextrose, and some degrade faster. Meropenem, for instance, maintained greater than 90% of its content for up to 4 hours at room temperature in 5% glucose but for up to 12 hours in 0.9% NaCl [10].
• Product-specific buffers: Some drugs require a buffer to maintain pH. Temocillin, for example, is reconstituted with 0.3% citrate buffer at pH 7 for stability in elastomeric infusion devices [11].

If the label specifies a diluent, use that one. If the label is silent, use the diluent your formulary or pharmacy protocol recommends.

Step 3: Swab the Stopper

Remove the plastic flip-off cap from the drug vial to expose the rubber stopper. Wipe the stopper with a 70% isopropyl alcohol swab and let it air dry for about 10 seconds. Do not blow on it. The alcohol needs time to kill surface organisms, and wiping alone is not enough. Do the same for the diluent vial if you are drawing from a multi-dose container.

Step 4: Draw Up the Diluent

Attach a needle to a syringe and draw up the exact volume of diluent specified on the label or in your protocol. If the label says to add 10 mL, measure 10 mL. Do not estimate. The final concentration depends on the volume you add, and a small error in volume becomes a larger error in concentration.

If you are using a multi-dose diluent vial, swab the stopper first. If you are using a single-dose vial or ampule, check for particulates before drawing.

Step 5: Inject the Diluent with Pressure Equalization

Insert the needle through the rubber stopper of the drug vial. Aim the needle at the wall of the vial rather than directly at the powder cake. Injecting directly onto the powder can create a hard clump that is difficult to dissolve.

As you inject, the pressure inside the vial will rise because you are adding liquid to a sealed container. If you keep injecting without venting, the pressure can push the plunger back or cause the stopper to leak. To equalize pressure, you can:

• Use a venting needle (a second needle inserted into the stopper to let air escape).
• Use a filter needle that allows air to pass but not liquid.
• Withdraw the needle slightly after injecting to let air escape, then reinsert.

Do not remove the needle completely while the vial is pressurized. Aerosolized drug can escape and contaminate the workspace.

Step 6: Swirl, Do Not Shake

Remove the syringe and needle. Hold the vial between your thumb and fingers and swirl it gently in a circular motion. The powder should dissolve within 30 seconds to a few minutes depending on the drug. Swirling mixes the liquid without introducing air.

Shaking is the most common mistake. Vigorous shaking creates foam, and foam is a problem for three reasons. First, it makes it hard to see whether the powder is fully dissolved. Second, foam can trap undissolved particles that you might draw into the syringe. Third, some proteins and drug molecules are sensitive to shear forces and can denature or aggregate when shaken. Swirl, wait, and swirl again if needed.

If the powder does not dissolve after a few minutes of swirling, check the label. Some products require a specific diluent or a specific temperature. Do not heat the vial unless the label says to.

Step 7: Inspect the Solution

Hold the vial up to the light. The solution should be clear and free of visible particles, unless the product is supposed to be cloudy (some suspensions are). Check the color against the label description. Cefuroxime solutions darken with time and heat [8]. Discoloration is a sign of degradation.

If you see particles, do not inject the solution. Swirl again. If particles persist, discard the vial and start over with a new one.

Step 8: Label and Store

Write the drug name, the final concentration, the date and time of reconstitution, and your initials on the vial. This label is what tells the next person when the beyond-use time expires.

Store the vial according to the product label. Refrigeration slows degradation for most drugs. Freezing stops it for some drugs but not all. Room temperature is acceptable only for short periods and only for drugs known to be stable at that temperature.

Concentration Calculations

The concentration of a reconstituted solution is the mass of drug divided by the total volume of liquid in the vial. The total volume is not just the volume of diluent you added. It is the volume of diluent plus the volume displaced by the powder itself.

Why the Final Volume Is Not the Diluent Volume

When you add 10 mL of diluent to a vial containing 1 g of powder, the final volume is slightly more than 10 mL because the powder takes up space. This is called the displacement volume. For many drugs, the displacement volume is small enough that the label provides a correction factor or states the final concentration directly. For example, a label might say "reconstitute with 10 mL of sterile water for injection to yield 100 mg/mL." In that case, the manufacturer has already accounted for displacement.

If the label does not state the final concentration, you can estimate it by dividing the mass of drug by the volume of diluent added. This gives you a slightly higher concentration than the true value, but the error is usually small. For precise work, use the label's stated concentration or measure the final volume.

Worked Example

Suppose you have a vial containing 1 g (1000 mg) of a drug. The label says to reconstitute with 10 mL of sterile water for injection. The label also states that the resulting concentration is 100 mg/mL.

• Mass of drug: 1000 mg
• Volume of diluent added: 10 mL
• Stated final concentration: 100 mg/mL

If you instead added 20 mL of diluent, the concentration would be approximately 50 mg/mL. If you added 5 mL, it would be approximately 200 mg/mL. The relationship is inverse: doubling the volume halves the concentration.

Stock Concentration Versus Final Concentration

The concentration in the vial after reconstitution is called the stock concentration. It is usually much higher than the concentration the patient receives. For example, a vial of meropenem might be reconstituted to 50 mg/mL as a stock, then diluted into an infusion bag to a final concentration of 4, 8, or 16 mg/mL [9]. The stock is a convenience. It lets you store a small volume and dilute as needed.

The distinction matters for two reasons. First, the stock may be stable for a different length of time than the diluted solution. Meropenem at 40 mg/mL in 0.9% sodium chloride was stable for a maximum of 8 hours at 25°C, while 10 and 20 mg/mL solutions were stable for 12 hours [3]. Higher concentration can mean faster degradation. Second, the stock may require a different diluent than the final infusion. Always check both the reconstitution instructions and the dilution instructions.

Diluent Selection Table

This table is a guide, not a substitute for the product label. Beyond-use times vary by drug, concentration, container, and storage temperature. Always confirm with the label and your formulary.

The Main Decision Path

The workflow below shows the decision sequence from vial verification to storage.

flowchart TD
    A[Verify vial label] --> B{Label specifies diluent}
    B -->|Yes| C[Use specified diluent]
    B -->|No| D[Use formulary default]
    C --> E[Swab stopper]
    D --> E
    E --> F[Inject diluent with venting]
    F --> G[Swirl do not shake]
    G --> H{Powder dissolved}
    H -->|No| I[Swirl longer or check label]
    H -->|Yes| J[Inspect solution]
    J --> K[Label with concentration and time]
    K --> L[Store per label]

Storage and Stability Notes

Storage is where reconstitution becomes a time-sensitive task. The same drug can be stable for hours at room temperature, days in the refrigerator, and months in the freezer, or it can degrade quickly in all three conditions depending on its chemistry.

Refrigeration

Refrigeration at 4°C is the default storage condition for most reconstituted drugs. It slows hydrolysis and oxidation without the risks of freezing. Cefuroxime sodium at 90 mg/mL lost less than 5% of its concentration after 14 days at 4°C, while the same solution fell below 60% after 1 day at 40°C [8]. Cefovecin sodium stored at 4°C showed delayed discoloration and smaller increases in MIC values compared to room temperature storage, though mild changes were still observed at later time points [2]. Meropenem and vaborbactam in polyvinyl chloride bags and elastomeric pumps remained stable at all tested concentrations for up to 144 hours under refrigeration [9].

Freezing

Freezing at -20°C can extend stability for drugs that tolerate it. Vancomycin and ceftazidime reconstituted and stored at -20°C were stable for 6 months [4]. Cefovecin sodium stored at -20°C preserved its physicochemical properties, antimicrobial activity, and measured drug concentrations throughout a 12-week study [2]. Meropenem in elastomeric devices stored at -19°C maintained stability, with the lowest concentration tested (6 mg/mL) remaining above 90% for up to 144 hours at 6.7°C and 72 hours after a 24-hour exposure at 22.5°C [12].

Freezing is not universal. Some drugs precipitate or degrade when frozen and thawed. Some containers crack. Always check the label before freezing.

Room Temperature

Room temperature storage is the least stable option for most reconstituted drugs. Meropenem at 25°C was stable for 12 hours at 10 and 20 mg/mL but only 8 hours at 40 mg/mL [3]. Cefovecin sodium at room temperature showed progressive discoloration, increased absorbance, elevated MIC values, and a significant decrease in drug concentration at later time points [2]. Amoxicillin and clavulanic acid in separate containers have been studied for continuous infusion, but clavulanic acid degrades rapidly at higher ambient temperatures, with up to 72.3% degradation in suspensions stored at 28°C over 7 days [6].

Discarding Unused Portions

Reconstituted solutions that are past their beyond-use time should be discarded. Do not save them for a later patient. Do not top off a partially used vial with fresh diluent. Do not use a solution that has changed color, developed particles, or been stored outside its labeled conditions.

Single-dose vials should be discarded after the dose is drawn, even if liquid remains. Multi-dose vials may be used until their beyond-use date if they contain a preservative and were handled aseptically. Preservative-free diluents and preservative-free drug vials are for single use only.

Preservative-Free Diluents for Special Routes

Preservatives such as benzyl alcohol, methylparaben, and propylparaben are added to some multi-dose vials to prevent bacterial growth. They are not safe for every route of administration.

• Intrathecal and epidural use: Preservatives can cause neurotoxicity. Use preservative-free diluents and preservative-free drug products.
• Ophthalmic use: Preservatives can damage the corneal endothelium and other ocular tissues. Intravitreal preparations such as vancomycin and ceftazidime are prepared with preservative-free diluents [4].
• Neonatal and small-animal use: Benzyl alcohol has been associated with toxicity in neonates. Use preservative-free products when the label specifies.
• Intravesical use: Mitomycin C for bladder instillation is reconstituted with the prepackaged diluent, which may be preservative-free saline or water [5].

If the label says preservative-free, use a preservative-free diluent. If you are unsure, ask your pharmacist.

Troubleshooting Table

Variations in Practice

Reconstitution is not always a simple powder-plus-liquid step. Some products require specific handling.

Automated reconstitution: Hospital pharmacies may use automated systems in cleanrooms to reconstitute antibiotics at high concentrations. Cefuroxime sodium at 1.5 g in 15, 16, or 18 mL of water for injection has been studied for centralized intravenous additive services, with content uniformity verified and stability monitored over time [1].

Elastomeric infusion devices: These are used for outpatient parenteral antimicrobial therapy. Temocillin reconstituted with 0.3% citrate buffer at pH 7 and stored in elastomeric devices retained greater than 97% of its concentration after 14 days at 5°C, then maintained 95% stability for 12 hours at 32°C for most concentrations tested [11]. Meropenem in elastomeric devices has been studied at 6, 12, 20, and 25 mg/mL, with the lowest concentration showing the highest stability [12].

Frozen aliquots: Some practices prepare individual doses in syringes and freeze them for later use. Vancomycin and ceftazidime stored at -20°C were stable for 6 months [4]. This practice requires careful labeling and aseptic technique.

Oral suspensions: Reconstituted dry powder suspensions for oral use often require refrigeration. Amoxicillin-clavulanic acid suspensions stored at 28°C showed up to 72.3% degradation of clavulanic acid over 7 days, compared to 12.9% at 8°C [6]. Refrigeration is not optional for these products.

Generic versus originator products: Generic formulations of cefepime, linezolid, and piperacillin/tazobactam have been compared to their originator drugs in healthy volunteers. Bioequivalence parameters were similar, and stability testing showed comparable results when stored according to their own specifications and those of the comparator products [13]. This suggests that generic products can be reconstituted and stored using the same principles, but always follow the specific product label.

Clinical Relevance, Limitations and Common Mistakes

Reconstitution is a small step in the chain of drug administration, but errors here propagate. A concentration error of 10% becomes a dosing error of 10%. A diluent error can cause precipitation, degradation, or toxicity. A storage error can turn a potent drug into a degraded mixture with reduced antimicrobial activity.

The most common mistakes are:

1. Using the wrong diluent. Saline and water are not interchangeable for every drug. Mitomycin C degraded faster in saline than in water [5].
2. Shaking instead of swirling. Foam traps undissolved particles and can denature sensitive drugs.
3. Ignoring displacement volume. The final concentration is not always mass divided by diluent volume. Use the label's stated concentration.
4. Storing at room temperature when refrigeration is required. Cefovecin sodium degraded faster at room temperature than at 4°C [2]. Meropenem at 40 mg/mL was stable for only 8 hours at 25°C [3].
5. Freezing drugs that should not be frozen. Not all drugs tolerate freezing. Check the label.
6. Using preservative-containing diluents for intrathecal or ophthalmic routes. Preservatives can be toxic by these routes.
7. Keeping reconstituted solutions past their beyond-use time. The beyond-use time is not a suggestion. It is the point beyond which stability and sterility are not assured.
8. Failing to label the vial. Without a label, the next person cannot know when the solution was made or what concentration it is.

Individual patients and individual products vary. A veterinarian who knows the patient, the drug, and the clinical context should make the final decision about reconstitution, dilution, and administration.

Frequently Asked Questions

What is a reconstitution solution?

A reconstitution solution is the liquid diluent you add to a dry powder drug to turn it into a usable liquid. It is usually sterile water for injection, 0.9% sodium chloride, 5% dextrose, or a product-specific buffer.

Can I use tap water to reconstitute a drug?

No. Tap water is not sterile and contains minerals and microorganisms that can contaminate the drug and change its chemistry. Always use a sterile diluent intended for injection.

Why should I swirl instead of shake the vial?

Swirling mixes the liquid without creating foam. Shaking introduces air, which traps undissolved particles and can damage shear-sensitive drug molecules.

How do I calculate the concentration after reconstitution?

Divide the mass of drug in the vial by the total volume of liquid in the vial. The total volume is the diluent volume plus the volume displaced by the powder. If the label states a final concentration, use that value.

What is the difference between stock concentration and final concentration?

Stock concentration is the concentration in the vial after reconstitution. Final concentration is the concentration after the stock is diluted into an infusion bag or other delivery vehicle. They are often different, and each has its own stability limits.

Can I freeze reconstituted drugs?

Some drugs can be frozen and some cannot. Vancomycin and ceftazidime were stable at -20°C for 6 months [4]. Cefovecin sodium preserved its properties at -20°C for 12 weeks [2]. Always check the product label before freezing.

Why does the diluent choice matter?

The diluent affects pH, osmolarity, and chemical stability. Mitomycin C degraded faster in saline than in water [5]. Meropenem degraded faster in 5% glucose than in 0.9% sodium chloride [10]. Use the diluent the label specifies.

What should I do with leftover reconstituted solution?

Discard it when the beyond-use time expires. Do not save it for another patient. Do not top off a partially used vial. Single-dose vials should be discarded after the dose is drawn.

Related Articles

• Dog Training Problems And Solutions
• Dog Behavior Problems And Solutions
• Dog Itchy Ear Solution
• Common Dog Behavior Problems And Solutions
• Stop Cat Scratching Furniture Solutions
• Dog Behavior Problems And Solutions At Home
• Hypotonic Solution: Definition, Effects, and Examples

Sources

1. Physicochemical stability of high-concentration cefuroxime aqueous injection reconstituted by a centralised intravenous additive service.
2. In vitro evaluation of temperature-dependent stability and antimicrobial activity of reconstituted cefovecin sodium.
3. Stability of generic brands of meropenem reconstituted in isotonic saline.
4. Stability of Vancomycin and Ceftazidime With Prolonged Storage at -20°C.
5. Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation.
6. Insufficient Stability of Clavulanic Acid in Widely Used Child-Appropriate Formulations.
7. Evaluation of Pharmacy-Developed Antibiotic Desensitization Protocols.
8. Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion.
9. Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric Devices.
10. Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
11. Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document.
12. An investigation of the stability of meropenem in elastomeric infusion devices.
13. Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers.